공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 심정지 치료 시장 : 치료별(의약품, 의료기기), 유통 채널별(병원, 독립형 약국) 시장 조사, 예측(-2025년), COVID-19의 누적 영향

Cardiac Arrest Treatment Market Research Report by Treatment, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2021년 06월 상품 코드 1001094
페이지 정보 영문 191 Pages
가격
US $ 3,949 ₩ 4,523,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 5,669,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 6,814,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 9,105,000 PDF (Site License) + Excel
US $ 9,949 ₩ 11,396,000 PDF (Enterprise License) + Excel


세계의 심정지 치료 시장 : 치료별(의약품, 의료기기), 유통 채널별(병원, 독립형 약국) 시장 조사, 예측(-2025년), COVID-19의 누적 영향 Cardiac Arrest Treatment Market Research Report by Treatment, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
발행일 : 2021년 06월 페이지 정보 : 영문 191 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 심정지 치료 시장 규모는 2020년 169억 2,357만 달러에서 2025년 말까지 249억 3,167만 달러로 성장할 것으로 예측됩니다.

COVID-19는 미증유의 세계적인 공중위생상 긴급사태이며, 모든 업계에 영향을 미쳐 왔습니다. 이 장기적 영향은 예측기간 중 업계의 성장에 영향을 미칠 것으로 예측됩니다. 우리가 진행하고 있는 조사에서는 기저에 있는 COVID-19의 문제와 향후 방향을 확실히 다루기 위해 조사 범위를 확대시키고 있습니다. 소비자의 행동과 수요 변화, 구입 패턴, 공급망 재라우팅, 현재 시장 동향 및 정부의 중요한 개입 등을 고려하면서, COVID-19에 대한 인사이트를 제공합니다. 업데이트된 조사에서는 COVID-19가 시장에 미치는 영향을 고려하고, 인사이트, 분석, 예측 등을 제공합니다.

세계의 심정지 치료(Cardiac Arrest Treatment) 시장에 대해 조사했으며, 시장 개요와 함께 치료별(의약품, 의료기기), 유통 채널별, 지역별 동향, COVID-19의 누적 영향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 범위
  • 조사 대상 연도
  • 통화와 가격
  • 언어
  • 제한
  • 이해관계자

제2장 조사 방법

  • 조사 과정
    • 정의 : 조사 목적
    • 결정 : 조사 디자인
    • 준비 : 조사 기기
    • 수집 : 데이터 소스
    • 분석 : 데이터 해석
    • 책정 : 데이터 검증
    • 공개 : 조사 보고서
    • 반복 : 보고서 갱신
  • 조사 실행
    • 개시 : 조사 과정
    • 계획 : 조사 계획 작성
    • 실행 : 조사 실시
    • 검증 : 발견과 분석
    • 출판물 : 조사 보고
  • 조사 성과

제3장 주요 요약

  • 서론
  • 시장 전망
  • 유통 채널별 전망
  • 치료별 전망
  • 지역별 전망
  • 경쟁사별 전망

제4장 시장 개요

  • 서론
  • COVID-19의 누적 영향

제5장 시장 인사이트

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
  • Porters Five Forces 분석
    • 신규 참여업체의 위협
    • 대체품의 위협
    • 고객의 협상력
    • 공급 기업의 협상력
    • 업계의 경쟁

제6장 세계의 심정지 치료 시장, 치료별

  • 의약품
    • 항부정맥제
    • 항콜린제
    • 베타 차단제
    • 코르티코스테로이드
    • 섬유소용해제
    • 승압제
  • 의료기기
    • 심장 재동기화 치료
    • 제세동기

제7장 세계의 심정지 치료 시장, 유통 채널별

  • 병원
  • 독립형 약국

제8장 아메리카의 심정지 치료 시장

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제9장 아시아태평양의 심정지 치료 시장

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 한국
  • 태국

제10장 유럽, 중동 및 아프리카의 심정지 치료 시장

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트
  • 영국

제11장 경쟁 상황

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 시장 점유율 분석
  • 경쟁사 SWOT 분석
  • 경쟁 시나리오
    • 합병과 인수
    • 합의, 협업 및 파트너십
    • 신제품 발매와 강화
    • 투자와 자금 조달
    • 상, 표창, 확대

제12장 기업 유저빌리티 개요

  • Abbott Laboratories
  • Amgen Inc.
  • Bayer AG
  • BIOTRONIK SE & CO., KG
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Cardiac Science Corporation
  • Fukuda Denshi Co., Ltd
  • GE Healthcare
  • GE Healthcare
  • Johnson & Johnson Services Inc
  • Koninklijke Philips N.V,
  • LivaNova PLC
  • Marshfield Clinic
  • Medtronic PLC
  • Neurescue
  • Nihon Kohden Corporation
  • Novartis International AG
  • Pfizer Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Stryker Corporation
  • ZOLL Medical Corporation

제13장 부록

  • 논의 가이드
  • 라이선스와 가격
KSM 21.04.29

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL CARDIAC ARREST TREATMENT MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL CARDIAC ARREST TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2026 (USD BILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2026
  • FIGURE 10. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2026 (USD BILLION)
  • FIGURE 11. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 12. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY ANTI-ARRHYTHMIC DRUGS, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY ANTI-ARRHYTHMIC DRUGS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY ANTICHOLINERGIC DRUGS, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY ANTICHOLINERGIC DRUGS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY BETA BLOCKERS, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY BETA BLOCKERS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, 2018-2026 (USD BILLION)
  • FIGURE 19. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY FIBRINOLYTIC DRUGS, 2018-2026 (USD BILLION)
  • FIGURE 21. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY FIBRINOLYTIC DRUGS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY VASOPRESSORS, 2018-2026 (USD BILLION)
  • FIGURE 23. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY VASOPRESSORS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 24. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2026 (USD BILLION)
  • FIGURE 25. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 26. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2026 (USD BILLION)
  • FIGURE 27. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 28. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATORS, 2018-2026 (USD BILLION)
  • FIGURE 29. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATORS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 30. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
  • FIGURE 31. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD BILLION)
  • FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
  • FIGURE 33. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2026 (USD BILLION)
  • FIGURE 34. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACIES, 2018-2026 (USD BILLION)
  • FIGURE 36. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 38. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 40. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 41. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 42. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 43. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 44. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 45. CALIFORNIA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 46. FLORIDA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 47. ILLINOIS CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 48. NEW YORK CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. OHIO CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 50. PENNSYLVANIA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 51. TEXAS CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 52. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 53. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 55. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. INDONESIA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. MALAYSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. PHILIPPINES CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 62. THAILAND CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 64. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 65. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 66. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 72. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 73. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 74. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 75. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 76. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 77. GLOBAL CARDIAC ARREST TREATMENT MARKET: FPNV POSITIONING MATRIX
  • FIGURE 78. GLOBAL CARDIAC ARREST TREATMENT MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 79. GLOBAL CARDIAC ARREST TREATMENT MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 80. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CARDIAC ARREST TREATMENT MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIAC ARREST TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY ANTI-ARRHYTHMIC DRUGS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY ANTICHOLINERGIC DRUGS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY BETA BLOCKERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY FIBRINOLYTIC DRUGS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY VASOPRESSORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. CALIFORNIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. CALIFORNIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. FLORIDA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. FLORIDA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. ILLINOIS CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. ILLINOIS CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. NEW YORK CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. NEW YORK CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. OHIO CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. OHIO CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. PENNSYLVANIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. PENNSYLVANIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. TEXAS CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. TEXAS CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. INDONESIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. INDONESIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. MALAYSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. MALAYSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. PHILIPPINES CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. PHILIPPINES CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. THAILAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. THAILAND CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. GLOBAL CARDIAC ARREST TREATMENT MARKET: SCORES
  • TABLE 90. GLOBAL CARDIAC ARREST TREATMENT MARKET: BUSINESS STRATEGY
  • TABLE 91. GLOBAL CARDIAC ARREST TREATMENT MARKET: PRODUCT SATISFACTION
  • TABLE 92. GLOBAL CARDIAC ARREST TREATMENT MARKET: RANKING
  • TABLE 93. GLOBAL CARDIAC ARREST TREATMENT MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 94. GLOBAL CARDIAC ARREST TREATMENT MARKET: SHARE, BY COMPANY, 2020
  • TABLE 95. GLOBAL CARDIAC ARREST TREATMENT MARKET: MERGER & ACQUISITION
  • TABLE 96. GLOBAL CARDIAC ARREST TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 97. GLOBAL CARDIAC ARREST TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 98. GLOBAL CARDIAC ARREST TREATMENT MARKET: INVESTMENT & FUNDING
  • TABLE 99. GLOBAL CARDIAC ARREST TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 100. GLOBAL CARDIAC ARREST TREATMENT MARKET: LICENSE & PRICING
  • TABLE 101. GLOBAL CARDIAC ARREST TREATMENT MARKET: CONTACT DETAILS

The Global Cardiac Arrest Treatment Market size was estimated at USD 16.92 Billion in 2020 and expected to reach USD 18.37 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 8.89% to reach USD 28.21 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Cardiac Arrest Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Treatment, the Cardiac Arrest Treatment Market was studied across Drug and Medical Devices. The Drug is further studied across Anti-arrhythmic Drugs, Anticholinergic Drugs, Beta Blockers, Corticosteroids, Fibrinolytic Drugs, and Vasopressors. The Medical Devices is further studied across Cardiac Resynchronization Therapy and Defibrillators.

Based on Distribution Channel, the Cardiac Arrest Treatment Market was studied across Hospitals and Independent Pharmacies.

Based on Geography, the Cardiac Arrest Treatment Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cardiac Arrest Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cardiac Arrest Treatment Market, including Abbott Laboratories, Amgen Inc., Bayer AG, BIOTRONIK SE & CO., KG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Cardiac Science Corporation, Fukuda Denshi Co., Ltd, GE Healthcare, GE Healthcare, Johnson & Johnson Services Inc, Koninklijke Philips N.V,, LivaNova PLC, Marshfield Clinic, Medtronic PLC, Neurescue, Nihon Kohden Corporation, Novartis International AG, Pfizer Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Stryker Corporation, and ZOLL Medical Corporation.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Cardiac Arrest Treatment Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cardiac Arrest Treatment Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cardiac Arrest Treatment Market?
  • 4. What is the competitive strategic window for opportunities in the Global Cardiac Arrest Treatment Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Cardiac Arrest Treatment Market?
  • 6. What is the market share of the leading vendors in the Global Cardiac Arrest Treatment Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Cardiac Arrest Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Distribution Channel Outlook
  • 3.4. Treatment Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiac disorders, such as coronary heart failures, heart attacks, strokes, and other heart-related conditions
      • 5.1.1.2. Rising sedentary lifestyle, and increase in the geriatric population
      • 5.1.1.3. Accelerating research on the evaluation and adoption of cardiac arrest therapies
    • 5.1.2. Restraints
      • 5.1.2.1. Expensive treatments associated with cardiac arrest and other heart-related disorders
    • 5.1.3. Opportunities
      • 5.1.3.1. Awareness related to advancements in medical devices for the treatment of cardiac arrest
      • 5.1.3.2. Emergence of minimally invasive procedures like percutaneous coronary interventions
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of advanced healthcare infrastructure and skilled professionals
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Cardiac Arrest Treatment Market, by Treatment

  • 6.1. Introduction
  • 6.2. Drug
    • 6.2.1. Anti-arrhythmic Drugs
    • 6.2.2. Anticholinergic Drugs
    • 6.2.3. Beta Blockers
    • 6.2.4. Corticosteroids
    • 6.2.5. Fibrinolytic Drugs
    • 6.2.6. Vasopressors
  • 6.3. Medical Devices
    • 6.3.1. Cardiac Resynchronization Therapy
    • 6.3.2. Defibrillators

7. Cardiac Arrest Treatment Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Independent Pharmacies

8. Americas Cardiac Arrest Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Cardiac Arrest Treatment Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Cardiac Arrest Treatment Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. Amgen Inc.
  • 12.3. Bayer AG
  • 12.4. BIOTRONIK SE & CO., KG
  • 12.5. Boston Scientific Corporation
  • 12.6. Bristol-Myers Squibb Company
  • 12.7. Cardiac Science Corporation
  • 12.8. Fukuda Denshi Co., Ltd
  • 12.9. GE Healthcare
  • 12.10. GE Healthcare
  • 12.11. Johnson & Johnson Services Inc
  • 12.12. Koninklijke Philips N.V,
  • 12.13. LivaNova PLC
  • 12.14. Marshfield Clinic
  • 12.15. Medtronic PLC
  • 12.16. Neurescue
  • 12.17. Nihon Kohden Corporation
  • 12.18. Novartis International AG
  • 12.19. Pfizer Inc.
  • 12.20. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 12.21. Stryker Corporation
  • 12.22. ZOLL Medical Corporation

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details
Back to Top
전화 문의
F A Q